China Medical Device Standards Management Annual Report (2023)
On February 2, 2024, the National Medical Products Administration (NMPA) pubulished the Medical Device Standards Management Anuual Report (2023) (hereinafter referred to as the [.....]
On February 2, 2024, the National Medical Products Administration (NMPA) pubulished the Medical Device Standards Management Anuual Report (2023) (hereinafter referred to as the [.....]
On 5 July 2023, Mr. Xu Jinghe, Deputy Commissioner of China’s National Medical Products Administration (NMPA), during the press conference “Talk by Authorities” illustrated [.....]
On 18 March 2021, the National Medical Products Administration issued the revised version of the Regulations on the Supervision and Administration of Medical Devices. [.....]
On March 30, the National Medical Products Administration (NMPA) and the Standardization Administration of China (SAC) jointly issued the Opinions on Further Promoting the [.....]
At the end of February 2021, the National Medical Products Administration (NMPA) released the "Annual Report on the Management of China's Medical Device Standards [.....]
On 2nd August CFDA released notice on registered information management for medical device production and operation license. The notice required the provincial level CFDA [.....]
On 2nd August, CFDA released management of imported medical devices agent (draft) for public comment. The draft defined clearly the requirements for agent and [.....]
On 25th June, the ministry of justice published the amended regulation on supervision and management of medical devices (draft) and called for public comments. [.....]
Sponsored by the COCIR, the seminar was held to facilitate communication between Chinese and Foreign medical device stakeholders in Tsinghua University on September 8, [.....]
The General Office of the State Council issued the “Guiding Opinions on Promoting the Healthy Development of the Pharmaceutical Industry” which aims to promote [.....]